MX337348B - Metodos para purificar virus utilizando cromatografia de permeacion en gel. - Google Patents

Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Info

Publication number
MX337348B
MX337348B MX2013012627A MX2013012627A MX337348B MX 337348 B MX337348 B MX 337348B MX 2013012627 A MX2013012627 A MX 2013012627A MX 2013012627 A MX2013012627 A MX 2013012627A MX 337348 B MX337348 B MX 337348B
Authority
MX
Mexico
Prior art keywords
methods
gel permeation
permeation chromatography
purifying viruses
viruses
Prior art date
Application number
MX2013012627A
Other languages
English (en)
Spanish (es)
Other versions
MX2013012627A (es
Inventor
Matthew C Coffey
Allison Hagerman
Roxna Kapadia
Sarah Serl
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of MX2013012627A publication Critical patent/MX2013012627A/es
Publication of MX337348B publication Critical patent/MX337348B/es

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
MX2013012627A 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel. MX337348B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161480561P 2011-04-29 2011-04-29
PCT/CA2012/000406 WO2012145837A1 (en) 2011-04-29 2012-04-27 Methods of purifying viruses using gel permeation chromatography

Publications (2)

Publication Number Publication Date
MX2013012627A MX2013012627A (es) 2014-05-13
MX337348B true MX337348B (es) 2016-02-29

Family

ID=47067091

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012627A MX337348B (es) 2011-04-29 2012-04-27 Metodos para purificar virus utilizando cromatografia de permeacion en gel.

Country Status (15)

Country Link
US (1) US20120273424A1 (enExample)
EP (1) EP2702147B1 (enExample)
JP (1) JP6029651B2 (enExample)
KR (2) KR20140024406A (enExample)
CN (1) CN103492557B (enExample)
AU (1) AU2012248082B2 (enExample)
CA (1) CA2832367A1 (enExample)
DK (1) DK2702147T3 (enExample)
EA (1) EA201391605A1 (enExample)
ES (1) ES2822199T3 (enExample)
IL (1) IL228491A (enExample)
MX (1) MX337348B (enExample)
SG (1) SG194449A1 (enExample)
TW (1) TW201307561A (enExample)
WO (1) WO2012145837A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2630012T3 (es) 2010-12-02 2017-08-17 Oncolytics Biotech Inc. Formulaciones virales liofilizadas
EA201390810A1 (ru) * 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
BR112015031541A2 (pt) 2013-06-17 2017-07-25 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport métodos para o impedimento da agregação de componentes virais
CN112384615A (zh) 2018-07-04 2021-02-19 普罗拜奥根股份公司 用于纯化包膜病毒的方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
CN114544815B (zh) * 2022-03-01 2023-10-27 中牧实业股份有限公司 一种山羊痘病毒的定量检测方法
CN116718524B (zh) * 2023-06-26 2025-11-07 西安交通大学 一种基于细胞膜色谱技术的病毒颗粒检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
ATE148165T1 (de) * 1989-07-24 1997-02-15 Bayer Ag Stabilisierung von hochgereinigten proteinen
BR9507657A (pt) * 1994-05-16 1997-09-09 Merck & Co Inc Proteina isolada e purificada de papilomavirus recombinante capsideos particulas semelhantes a virus processos a virus processos para produzir a proteina para tratar ou prevenir a infecçao por papilomavirus para produzir uma proteina de capsideo de papilomavirus recombinante montada em um capsideo ou particula semelhante a virus e para induzir uma resposta imune em um animal vertebrado composiçoes farmacêuticas kit para a detecçao de papilomavirus ou anticorpos para papilomavirus e sistema sinte
CA2723040A1 (en) * 1998-02-17 1999-08-19 Schering Corporation Compositions comprising viruses and methods for concentrating virus preparations
JP4087712B2 (ja) 2001-03-16 2008-05-21 オンコリティクス バイオテック, インコーポレイティッド 細胞培養物からウイルスを抽出する方法
ATE427990T1 (de) * 2002-04-30 2009-04-15 Oncolytics Biotech Inc Verbesserte reinigungsmethode fur viren
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
JP5326155B2 (ja) * 2006-08-07 2013-10-30 一般財団法人化学及血清療法研究所 痘瘡生ワクチンの製造方法
DK2132315T3 (en) * 2007-03-12 2015-10-19 Oncolytics Biotech Inc Reoviruses with modified sequences
CN102089324B (zh) * 2007-11-12 2014-04-16 特罗科隆科学有限公司 用于对流行性感冒进行治疗以及诊断的组合物以及方法
US8227577B2 (en) * 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
EA201390810A1 (ru) * 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
ES2630012T3 (es) * 2010-12-02 2017-08-17 Oncolytics Biotech Inc. Formulaciones virales liofilizadas

Also Published As

Publication number Publication date
IL228491A0 (en) 2013-12-31
JP2014516515A (ja) 2014-07-17
CA2832367A1 (en) 2012-11-01
EP2702147B1 (en) 2020-07-15
WO2012145837A1 (en) 2012-11-01
AU2012248082B2 (en) 2015-08-20
US20120273424A1 (en) 2012-11-01
CN103492557A (zh) 2014-01-01
EP2702147A1 (en) 2014-03-05
KR102151890B1 (ko) 2020-09-03
JP6029651B2 (ja) 2016-11-24
IL228491A (en) 2017-05-29
CN103492557B (zh) 2015-07-29
EP2702147A4 (en) 2014-11-05
KR20190026059A (ko) 2019-03-12
SG194449A1 (en) 2013-12-30
ES2822199T3 (es) 2021-04-29
EA201391605A1 (ru) 2014-02-28
DK2702147T3 (da) 2020-09-28
AU2012248082A1 (en) 2013-05-09
KR20140024406A (ko) 2014-02-28
MX2013012627A (es) 2014-05-13
TW201307561A (zh) 2013-02-16

Similar Documents

Publication Publication Date Title
SG194449A1 (en) Methods of purifying viruses using gel permeation chromatography
EP2691170A4 (en) BIN-FREE ZEOLITIC ADSORPTION AGENTS, METHOD FOR PRODUCING BINDER-FREE ZEOLITIC ADSORPTION AGENTS, AND ADSORPTIVE SEPARATION PROCESSES USING BINDING-FREE ZEOLITE ADSORPTION AGENTS
MD20150062A2 (ro) Compuşi antivirali
MX392274B (es) Cartuchos utiles en limpieza de soluciones de dialisis.
SG10201902924RA (en) Antibodies that bind ebola glycoprotein and uses thereof
WO2013078170A8 (en) Purification of anti-c-met antibodies
MX2015011199A (es) Agentes terapéuticos de csf1.
MY195289A (en) Anti IL-36R Antibodies
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
ECSP13013060A (es) Composiciones de nucleasa terapéuticas y métodos
IN2014KN02831A (enExample)
MX2010004892A (es) Terapia de combinacion para tratar infecciones virales persistentes.
MX360245B (es) Composiciones que comprenden inmunoglobulinas de tipo secretor.
WO2013028334A3 (en) Use of small molecules in methods for purification of biomolecules
MX2019006568A (es) Eliminacion de ligandos lixiviados de purificacion de afinidad.
TN2013000388A1 (en) Anticoagulant antidotes
BR112016022214A2 (pt) rnase para uso no tratamento ou prevenção de infecções virais
WO2012139106A3 (en) Herpes simplex virus
IT1399575B1 (it) Sistema di aggancio perfezionato per settori di prolunga su banco di stesa per vibrofinitrice stradale, banco di stesa e vibrofinitrice comprendenti detto sistema di aggancio.
MX2018003080A (es) Cartuchos utiles en soluciones de dialisis de limpieza.
EP3169431A4 (en) High efficiency, ultra-stable, bonded hydrophilic interaction chromatography (hilic) matrix on superficially porous particles (spps)
PE20170586A1 (es) Nuevo uso de n,n-bis-2-mercaptoetil isoftalamida
BR112014023946A8 (pt) Um sistema de elemento de desgaste
WO2012164003A3 (de) Solareinrichtung mit reflektorvorrichtung und reflektorvorrichtung
PH12014501285A1 (en) Liquid activation system

Legal Events

Date Code Title Description
FG Grant or registration